{"id":11081,"date":"2003-05-01T14:56:32","date_gmt":"2003-05-01T14:56:32","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=11081"},"modified":"2014-05-28T13:04:17","modified_gmt":"2014-05-28T13:04:17","slug":"t-20-access-programme-to-continue-in-uk-for-a-further-two-months","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/11081","title":{"rendered":"T-20 access programme to continue in UK for a further two months"},"content":{"rendered":"<p><strong>The programme providing access to T-20 prior to market approval was originally scheduled to run from November 2002 to March 2003.<\/strong><\/p>\n<p>However, Roche has announced that it will be extending this for a further two months \u201cto tide us over to launch of T-20, which is expected [in Europe] in late May\/June 2003\u201d. Criteria and logistics remain the same for this extended time period and includes a commitment to provide free drug during this period and until one month after launch. Any patient resident in the UK is eligible for consideration.<\/p>\n<p>Anyone interested in more information on this programme or wishing to register a patient should call Julia Nicholson on 01707 6234.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The programme providing access to T-20 prior to market approval was originally scheduled to run from November 2002 to March 2003. However, Roche has announced that it will be extending this for a further two months \u201cto tide us over &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-11081","post","type-post","status-publish","format-standard","hentry","category-antiretrovirals"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/11081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=11081"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/11081\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=11081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=11081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=11081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}